Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB12 (Proposed Pembrolizumab Biosimilar) to Keytruda® in Non-small Cell Lung Cancer (BENITO Study)Non Squamous Non Small Cell Lung CancerActive, not recruitingPhase 32026-09-10NCT06687369

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
mAbxience Research S.L.2

172 results · Page 1 of 7

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Site 101001YerevanArmenia1
Site 101002YerevanArmenia1
Site 101003YerevanArmenia1
Site 101004YerevanArmenia1
Site 103001SarajevoBosnia and Herzegovina1
Site 103002TuzlaBosnia and Herzegovina1
Site 103003ZenicaBosnia and Herzegovina1
Site 108001TbilisiGeorgia1
Site 108002TbilisiGeorgia1
Site 108003TbilisiGeorgia1
Site 108004BatumiGeorgia1
Site 108005KutaisiGeorgia1
Site 108006TbilisiGeorgia1
Site 108007TbilisiGeorgia1
Site 108008TbilisiGeorgia1
Site 108009TbilisiGeorgia1
Site 108010TbilisiGeorgia1
Site 108011MarneuliGeorgia1
Site 108012TbilisiGeorgia1
Site 110001ThessalonikiGreece1
Site 110002ThessalonikiGreece1
Site 110003KifissiaGreece1
Site 110004LarissaGreece1
Site 110005ThessalonikiGreece1
Site 110006AthensGreece1